PGR and thyroid gland papillary carcinoma: Oestrogen also has been implicated in melanoma [24] and papillary thyroid cancer development [25] whereas progesterone appears to play a role in meningiomas [26], leading to trials with mifepristone, the progesterone receptor antagonist [27].